Direxion Nanotechnology ETF
TYNE
TYNE was delisted on the 17th of February, 2023.
5 hedge funds and large institutions have $1.12M invested in Direxion Nanotechnology ETF in 2022 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
17% less funds holding
Funds holding: 6 → 5 (-1)
24% less capital invested
Capital invested by funds: $1.48M → $1.12M (-$361K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$68K |
TYNE Hedge Fund Activity: Q2 2022 in Review
5 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Direxion Nanotechnology ETF (TYNE) for Q2 2022, worth a combined $1.12M — down 24% from $1.48M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of TYNE and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was JP Morgan Chase, exiting entirely with an estimated $68K sold.
- 5 institutional investors held Direxion Nanotechnology ETF (TYNE) as of Q2 2022, down from 6 in Q1 2022.
- Funds reported $1.12M of Direxion Nanotechnology ETF stock for Q2 2022, down 24% quarter-over-quarter.
- 0 funds opened new Direxion Nanotechnology ETF positions in Q2 2022 and 1 closed out, a net change of -1 holder.
- The largest Direxion Nanotechnology ETF seller in Q2 2022 was JP Morgan Chase, an estimated $68K sold.
Based on aggregated 13F filings for Q2 2022.